250 related articles for article (PubMed ID: 31608980)
21. Cyclodextrin triggers MCOLN1-dependent endo-lysosome secretion in Niemann-Pick type C cells.
Vacca F; Vossio S; Mercier V; Moreau D; Johnson S; Scott CC; Montoya JP; Moniatte M; Gruenberg J
J Lipid Res; 2019 Apr; 60(4):832-843. PubMed ID: 30709900
[TBL] [Abstract][Full Text] [Related]
22. Activation of mammalian terget of rapamycin kinase and glycogen synthase kinase-3β accompanies abnormal accumulation of cholesterol in fibroblasts from Niemann-Pick type C patients.
Wos M; Komiażyk M; Pikula S; Tylki-Szymanska A; Bandorowicz-Pikula J
J Cell Biochem; 2019 Apr; 120(4):6580-6588. PubMed ID: 30390318
[TBL] [Abstract][Full Text] [Related]
23. [Annexins in Niemann-Pick type C disease].
Buszewska ME; Strzelecka-Kiliszek A; Tylki-Szymańska A; Bandorowicz-Pikuła J
Postepy Biochem; 2007; 53(2):169-73. PubMed ID: 17969878
[TBL] [Abstract][Full Text] [Related]
24. Overview of clinical, molecular, and therapeutic features of Niemann-Pick disease (types A, B, and C): Focus on therapeutic approaches.
Hosseini K; Fallahi J; Razban V; Sirat RZ; Varasteh M; Tarhriz V
Cell Biochem Funct; 2024 Jun; 42(4):e4028. PubMed ID: 38715125
[TBL] [Abstract][Full Text] [Related]
25. Restarting stalled autophagy a potential therapeutic approach for the lipid storage disorder, Niemann-Pick type C1 disease.
Sarkar S; Maetzel D; Korolchuk VI; Jaenisch R
Autophagy; 2014 Jun; 10(6):1137-40. PubMed ID: 24879158
[TBL] [Abstract][Full Text] [Related]
26. δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders.
Xu M; Liu K; Swaroop M; Porter FD; Sidhu R; Firnkes S; Ory DS; Marugan JJ; Xiao J; Southall N; Pavan WJ; Davidson C; Walkley SU; Remaley AT; Baxa U; Sun W; McKew JC; Austin CP; Zheng W
J Biol Chem; 2012 Nov; 287(47):39349-60. PubMed ID: 23035117
[TBL] [Abstract][Full Text] [Related]
27. Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems.
Völkner C; Pantoom S; Liedtke M; Lukas J; Hermann A; Frech MJ
Cells; 2022 Jan; 11(3):. PubMed ID: 35159129
[TBL] [Abstract][Full Text] [Related]
28. Cholesterol-dependent increases in glucosylceramide synthase activity in Niemann-Pick disease type C model cells: Abnormal trafficking of endogenously formed ceramide metabolites by inhibition of the enzyme.
Hashimoto N; Matsumoto I; Takahashi H; Ashikawa H; Nakamura H; Murayama T
Neuropharmacology; 2016 Nov; 110(Pt A):458-469. PubMed ID: 27539961
[TBL] [Abstract][Full Text] [Related]
29. In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C.
Yasmin N; Ishitsuka Y; Fukaura M; Yamada Y; Nakahara S; Ishii A; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Okada Y; Nishikawa J; Ichikawa A; Iohara D; Hirayama F; Higaki K; Ohno K; Matsuo M; Irie T
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845767
[TBL] [Abstract][Full Text] [Related]
30. Dietary plant stanol ester supplementation reduces peripheral symptoms in a mouse model of Niemann-Pick type C1 disease.
Magro Dos Reis I; Houben T; Oligschläger Y; Bücken L; Steinbusch H; Cassiman D; Lütjohann D; Westerterp M; Prickaerts J; Plat J; Shiri-Sverdlov R
J Lipid Res; 2020 Jun; 61(6):830-839. PubMed ID: 32291331
[TBL] [Abstract][Full Text] [Related]
31. Pre-mRNA splicing defects and RNA binding protein involvement in Niemann Pick type C disease.
Paron F; Dardis A; Buratti E
J Biotechnol; 2020 Jul; 318():20-30. PubMed ID: 32387451
[TBL] [Abstract][Full Text] [Related]
32. The pathogenesis of Niemann-Pick type C disease: a role for autophagy?
Pacheco CD; Lieberman AP
Expert Rev Mol Med; 2008 Sep; 10():e26. PubMed ID: 18782459
[TBL] [Abstract][Full Text] [Related]
33. An "exacerbate-reverse" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease.
Munkacsi AB; Chen FW; Brinkman MA; Higaki K; Gutiérrez GD; Chaudhari J; Layer JV; Tong A; Bard M; Boone C; Ioannou YA; Sturley SL
J Biol Chem; 2011 Jul; 286(27):23842-51. PubMed ID: 21489983
[TBL] [Abstract][Full Text] [Related]
34. Laboratory diagnosis of the Niemann-Pick type C disease: an inherited neurodegenerative disorder of cholesterol metabolism.
Sitarska D; Ługowska A
Metab Brain Dis; 2019 Oct; 34(5):1253-1260. PubMed ID: 31197681
[TBL] [Abstract][Full Text] [Related]
35. Lipid trafficking defects increase Beclin-1 and activate autophagy in Niemann-Pick type C disease.
Pacheco CD; Lieberman AP
Autophagy; 2007; 3(5):487-9. PubMed ID: 17611388
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma as a complication of Niemann-Pick disease type C1.
Rodriguez-Gil JL; Bianconi SE; Farhat N; Kleiner DE; Nelson M; Porter FD
Am J Med Genet A; 2021 Oct; 185(10):3111-3117. PubMed ID: 34138521
[TBL] [Abstract][Full Text] [Related]
37. Targeting the autophagy-NAD axis protects against cell death in Niemann-Pick type C1 disease models.
Kataura T; Sedlackova L; Sun C; Kocak G; Wilson N; Banks P; Hayat F; Trushin S; Trushina E; Maddocks ODK; Oblong JE; Miwa S; Imoto M; Saiki S; Erskine D; Migaud ME; Sarkar S; Korolchuk VI
Cell Death Dis; 2024 May; 15(5):382. PubMed ID: 38821960
[TBL] [Abstract][Full Text] [Related]
38. Adenosine A
De Nuccio C; Bernardo A; Ferrante A; Pepponi R; Martire A; Falchi M; Visentin S; Popoli P; Minghetti L
Sci Rep; 2019 Jul; 9(1):9782. PubMed ID: 31278313
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.
Helquist P; Maxfield FR; Wiech NL; Wiest O
Neurotherapeutics; 2013 Oct; 10(4):688-97. PubMed ID: 24048860
[TBL] [Abstract][Full Text] [Related]
40. PEG-lipid micelles enable cholesterol efflux in Niemann-Pick Type C1 disease-based lysosomal storage disorder.
Brown A; Patel S; Ward C; Lorenz A; Ortiz M; DuRoss A; Wieghardt F; Esch A; Otten EG; Heiser LM; Korolchuk VI; Sun C; Sarkar S; Sahay G
Sci Rep; 2016 Aug; 6():31750. PubMed ID: 27572704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
